Michael Dong recently discussed sample preparation (SP) techniques for small-molecule drug substances and solid dosage forms.

Q2 2025 Earnings Conference Call May 12, 2025 4:30 PM ET. Company Participants. Vincent Anzalone - Vice President of Investor Relatio ...

Researchers at UC Santa Barbara, UCSF and the University of Pittsburgh have developed a new workflow for designing enzymes from scratch, paving the way toward more efficient, powerful and ...

LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced financial and operational ...

With growing uncertainty in the US, Chinese companies are swooping in to present themselves as stable, open partners to the ...

Teos ends belrestotug program with GSK after Phase 2 trial fails to meet key survival goals; company explores strategic options to boost shareholder value.

It's not quite as bad as The Last of Us. But progress has been achingly slow in developing new antifungal vaccines and drugs.

Eton Pharmaceuticals, Inc ("Eton” or "the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported ...

As summer approaches, millions of Americans begin planning or taking trips to state and national parks, seeking to explore ...

Mineralys Therapeutics, Inc. ( NASDAQ: MLYS) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET ...

Swiss pharmaceutical and diagnostics giant Roche pledged on Monday to inject at least $700 million into the construction of a new plant in the United States.

Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical trialTen globally leading transplant hospitals are ...